BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31620947)

  • 21. Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome.
    Sereni L; Castiello MC; Di Silvestre D; Della Valle P; Brombin C; Ferrua F; Cicalese MP; Pozzi L; Migliavacca M; Bernardo ME; Pignata C; Farah R; Notarangelo LD; Marcus N; Cattaneo L; Spinelli M; Giannelli S; Bosticardo M; van Rossem K; D'Angelo A; Aiuti A; Mauri P; Villa A
    J Allergy Clin Immunol; 2019 Sep; 144(3):825-838. PubMed ID: 30926529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant glycosylation of IgA in Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
    Shimizu M; Kanegane H; Wada T; Motoyoshi Y; Morio T; Candotti F; Yachie A
    J Allergy Clin Immunol; 2013 Feb; 131(2):587-90.e1-3. PubMed ID: 23107152
    [No Abstract]   [Full Text] [Related]  

  • 23. Prophylactic platelet transfusion in children with thrombocytopenic disorders: a retrospective review.
    Ferrara M; Capozzi L; Coppola A; Save G; Coppola L
    Hematology; 2007 Aug; 12(4):297-9. PubMed ID: 17654055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of 28 novel mutations in the Wiskott-Aldrich syndrome and X-linked thrombocytopenia based on multiplex PCR.
    Proust A; Guillet B; Picard C; de Saint Basile G; Pondarré C; Tamary H; Dreyfus M; Tchernia G; Fischer A; Delaunay J
    Blood Cells Mol Dis; 2007; 39(1):102-6. PubMed ID: 17400488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intermittent low platelet counts hampering diagnosis of X-linked thrombocytopenia in children: report of two unrelated cases and a novel mutation in the gene coding for the Wiskott-Aldrich syndrome protein.
    Medina SS; Siqueira LH; Colella MP; Yamaguti-Hayakawa GG; Duarte BKL; Dos Santos Vilela MM; Ozelo MC
    BMC Pediatr; 2017 Jun; 17(1):151. PubMed ID: 28641574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematopoietic stem cell transplantation for X-linked thrombocytopenia from a mild symptomatic carrier.
    Okuya M; Kurosawa H; Kubota T; Endoh K; Ogiwara A; Nonoyama S; Hagisawa S; Sato Y; Matsushita T; Fukushima K; Sugita K; Sato T; Arisaka O
    Bone Marrow Transplant; 2010 Mar; 45(3):607-9. PubMed ID: 19684625
    [No Abstract]   [Full Text] [Related]  

  • 27. Hereditary thrombocytopenia: relation to Wiskott-Aldrich syndrome with special reference to splenectomy. Report of a family and review of the literature.
    Weiden PL; Blaese RM
    J Pediatr; 1972 Feb; 80(2):226-34. PubMed ID: 4550450
    [No Abstract]   [Full Text] [Related]  

  • 28. IVS6+5G>A found in Wiskott-Aldrich syndrome and X-linked thrombocytopenia in a Korean family.
    Yoon SH; Cho T; Kim HJ; Kim SY; Ko JH; Baek HS; Lee HJ; Lee CH
    Pediatr Blood Cancer; 2012 Feb; 58(2):297-9. PubMed ID: 22038941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermittent X-linked thrombocytopenia with a novel WAS gene mutation.
    Wada T; Itoh M; Maeba H; Toma T; Niida Y; Saikawa Y; Yachie A
    Pediatr Blood Cancer; 2014 Apr; 61(4):746-8. PubMed ID: 24115682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. X-linked thrombocytopenia in a girl.
    Inoue H; Kurosawa H; Nonoyama S; Imai K; Kumazaki H; Matsunaga T; Sato Y; Sugita K; Eguchi M
    Br J Haematol; 2002 Sep; 118(4):1163-5. PubMed ID: 12199801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow transplantation for the Wiskott-Aldrich syndrome. Long-term follow-up.
    Rimm IJ; Rappeport JM
    Transplantation; 1990 Oct; 50(4):617-20. PubMed ID: 2219285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Splenectomy in the Wiskott-Aldrich syndrome.
    Nathan DG
    N Engl J Med; 1980 Apr; 302(16):916-7. PubMed ID: 6767188
    [No Abstract]   [Full Text] [Related]  

  • 33. Quality of life in Malaysian children with epilepsy.
    Fong CY; Chang WM; Kong AN; Rithauddin AM; Khoo TB; Ong LC
    Epilepsy Behav; 2018 Mar; 80():15-20. PubMed ID: 29396357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The need to support caregivers during pediatric bone marrow transplantation (BMT): A case report.
    Mangurian C; Packman W; Riano NS; Kearney J
    Palliat Support Care; 2018 Jun; 16(3):367-370. PubMed ID: 29380715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Wiskott-Aldrich syndrome].
    Gulácsy V; Maródi L
    Orv Hetil; 2008 Jul; 149(29):1367-71. PubMed ID: 18617469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current and emerging treatment options for Wiskott-Aldrich syndrome.
    Worth AJ; Thrasher AJ
    Expert Rev Clin Immunol; 2015; 11(9):1015-32. PubMed ID: 26159751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Confirming or excluding the diagnosis of Wiskott-Aldrich syndrome in children with thrombocytopenia of an unknown etiology.
    Ariga T; Nakajima M; Yoshida J; Yamato K; Nagatoshi Y; Yanai F; Caviles AP; Nelson DL; Sakiyama Y
    J Pediatr Hematol Oncol; 2004 Jul; 26(7):435-40. PubMed ID: 15218418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membranous nephropathy in a female patient with X-linked thrombocytopenia.
    Okada M; Nagasawa M; Oshiba A; Kawaguchi H
    Pediatr Nephrol; 2023 Aug; 38(8):2873-2876. PubMed ID: 36451038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgA nephropathy associated with X-linked thrombocytopenia.
    Matsukura H; Kanegane H; Miya K; Ohtsubo K; Higuchi A; Tanizawa T; Miyawaki T
    Am J Kidney Dis; 2004 Mar; 43(3):e7-12. PubMed ID: 14981635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options.
    Albert MH; Bittner TC; Nonoyama S; Notarangelo LD; Burns S; Imai K; Espanol T; Fasth A; Pellier I; Strauss G; Morio T; Gathmann B; Noordzij JG; Fillat C; Hoenig M; Nathrath M; Meindl A; Pagel P; Wintergerst U; Fischer A; Thrasher AJ; Belohradsky BH; Ochs HD
    Blood; 2010 Apr; 115(16):3231-8. PubMed ID: 20173115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.